<DOC>
	<DOCNO>NCT02271425</DOCNO>
	<brief_summary>Evacetrapib ( study drug ) investigational drug develop aim help people high risk heart problem future . In study compare much study drug get blood stream give single dose ( tablet form ) compare intravenous injection ( give directly vein via small needle ) . The study expect last least 15 day participant , include screen . Screening occur 28 day study drug give .</brief_summary>
	<brief_title>A Study Measure Amount Evacetrapib That Enters Blood Stream Healthy Participants</brief_title>
	<detailed_description />
	<mesh_term>Evacetrapib</mesh_term>
	<criteria>Are overtly healthy male female , determine medical history physical examination Female participant post menopausal woman woman child bear potential due surgical sterilization ( least 6 week surgical hysterectomy , bilateral oophorectomy , tubal occlusion ) confirm medical history , menopause Have body mass index ( BMI ) less 32 kilogram per square meter ( kg/m^2 ) Have give write informed consent approve Eli Lilly Company ethical review board ( ERB ) govern site Have know allergy evacetrapib , related compound component formulation , intolerance alcohol containing product , history significant allergic disease determine investigator Have abnormal blood pressure determine investigator Have history presence cardiovascular , respiratory , hepatic , renal , gastrointestinal , endocrine , hematological , neurological disorder capable significantly alter absorption , metabolism , elimination drug ; constitute risk take study medication ; interfere interpretation data Regularly use know drug abuse and/or show positive finding urinary drug screen Show evidence human immunodeficiency virus ( HIV ) infection and/or positive human HIV antibody Are woman pregnant lactate Have use intend use overthecounter prescription medication ( include vitamins/mineral supplements/herbal medicine ) 14 day prior first dose study . The use topical medicine , provide evidence chronic dosing risk systemic exposure , occasional acetaminophen acceptable Have donate blood 500 milliliter ( mL ) within last 3 month Are unwilling comply dietary requirements/restrictions study : Consume meal provide inpatient appointment , Refrain eat food drinking beverage contain grapefruit , grapefruit juice , Seville oranges , Seville orange juice , star fruit , pomelo , commercial apple juice orange juice least 7 day prior first dose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>